ARCHIVES

GAO Report Finds Hydrazine Sulfate Trials Were Accurate

This article is from The Cancer Letter archive.

Vol. 21 No. 37 | September 29, 1995

Download PDF Visit The Full Archive

Related Articles

NCAB Supports ACS Effort To Work With Centers

March 1, 1991

Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial

June 1, 2001

NIH Offers Grant Funds for Support of Minority, Disabled Researchers

February 16, 1996

Advocacy Groups Form Council To Lobby For Cancer Programs To Benefit Minorities

April 28, 1995

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

April 21, 2006

Mozobil Plus G-CSF Increases Rate Of Cell Mobilization

September 30, 2005